{
    "organizations": [],
    "uuid": "0c5c682b65850d13af1ae7b39b2b253a568482de",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-initiator-pharma-receives-intentio/brief-initiator-pharma-receives-intention-to-grant-notice-for-patent-application-idUSFWN1PP0FK",
    "ord_in_thread": 0,
    "title": "BRIEF-Initiator Pharma Receives Intention To Grant Notice For Patent Application",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 30 (Reuters) - INITIATOR PHARMA A/S:\n* INITIATOR PHARMA RECEIVES AN INTENTION TO GRANT NOTICE IN EUROPE FOR ITS PIPELINE PRODUCT CANDIDATE IPDP2015 FOR TREATMENT OF DEPRESSION\n* SAYS ‍PATENT, WHEN GRANTED, PROVIDES PROTECTION OF IPDP2015 IN EUROPE UNTIL 2029​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-01-30T17:08:00.000+02:00",
    "crawled": "2018-01-31T16:37:01.011+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "initiator",
        "pharma",
        "initiator",
        "pharma",
        "receives",
        "intention",
        "grant",
        "notice",
        "europe",
        "pipeline",
        "product",
        "candidate",
        "ipdp2015",
        "treatment",
        "depression",
        "say",
        "granted",
        "provides",
        "protection",
        "ipdp2015",
        "europe",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}